Health Dictionary Find a Doctor

Gangrene

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D. [2]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Gangrene is a medical condition that involves necrosis and ischemia of a body tissue, mostly occurring in the digits or extremities. It usually appears as a black discoloration and sloughing of tissues. There are three main types of gangrene, namely wet gangrene, dry gangrene, and gas gangrene.

Historical Perspective

Gangrene originated from a Greek word that meant mortification of a human body part. It was first used as a noun in the British Isles during the 16th century. Surgeons most often used it to refer to the cure of external human conditions.

Classification

There are three main types of gangrene which include wet, dry, and gas gangrene. Sometimes it can be classified according to its site.

Pathophysiology

There are three types of gangrene and they have different pathophysiology. A reduced arterial perfusion is observed in dry gangrene which results in the compensatory arteriolar dilation, which eventually results in distal edema, and damage of the endothelial tissue. Saprogenic microorganisms such as Clostridium perfringens and Bacillus fusiformis are the most common organisms observed in wet gangrene which are responsible for infecting the tissues, thereby producing a putrid smell and edema. Group A Steptococcus and exotoxins from Clostridium perfringens are responsible for the local and systemic infection found in gas gangrene.

Causes

According to Hippocratic physicians, gangrene is brought about by three reasons. These include wound constriction that is followed by hemorrhage, body part compression, and necrosis due to bandages.

Differentiating Gangrene from other Diseases

Gangrene can have several mimicking conditions despite the unique presence of necrotic tissue.

Epidemiology and Demographics

Ischemic or dry gangrene is commonly associated with peripheral artery disease (PAD). The most advanced stage of PAD is critical limb ischemia/ chronic limb-threatening ischemia, and it has an incidence rate of 1% in the United States. Gas gangrene is a rare condition, with an annual record of 1000 cases in the United States, 50% of which are due to traumatic injuries, 30% due to post-operative complications, and the remaining part is attributed to infections.

Risk Factors

There are several risk factors for gangrene and these include penetrating trauma, blunt trauma, recent surgery, obesity, alcoholism, mucosal breach, skin breach, and immunosuppression.

Natural History, Complications, and Prognosis

Amputation and death are the most common consequence of critical limb ischemia/ chronic limb-threatening ischemia. Gas gangrene has higher fatality rate, ranging from 25% to 100%, if treatment is inadequate or delayed. Increased age, several comorbidities present, and involvement of trunk lead to a poor prognosis.

Diagnosis

History and Symptoms

Chronic limb pain is the usual chief complaint of patients who developed gangrene.

Physical Examination

Patients with gangrene may have varying presentations depending on the type of gangrene they have.

Laboratory Findings

Evaluation of patients with ischemic gangrene is more focused on targeting the risk factors which include hyperlipidemia, diabetes, and renal failure. Laboratory tests to deal with these risk factors are usually requested for ischemic gangrene. Wet gangrene and gas gangrene are assessed with the help of cultures.

X-ray

X-rays are utilized in the evaluation of gas gangrene to identify any present subcutaneous gas.

CT scan

Computed tomography (CT scan) with contrast is the best initial imaging test for gangrene.

MRI

Magnetic resonance imaging (MRI) is not so useful in the evaluation of gas gangrene. The presence of gas is not very well detected using this imaging modality.

Other Imaging Findings

Other recommended imaging tests to consider in the evaluation of gangrene include ultrasound, duplex ultrasound, computed tomography / (CT) angiography, digital subtraction angiography, and magnetic resonance angiography / (MRA).

Other Diagnostic Studies

There are some useful tools that were developed to assess the possibility of gangrene. These include the recent development of the Society of Vascular Surgery which is called WIfI which stands for wound, ischemia, foot infection, and the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score.

Treatment

Medical Therapy

Ischemic gangrene can be medically treated with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and antiplatelet drugs such as aspirin and clopidogrel. Wet gangrene and gas gangrene are treated with antibiotics which should cover microorganisms detected in culture of the specimen with gangrene.

Surgery

The goal of surgical treatment in gangrene is to achieve revascularization to alleviate pain and avoid limb loss.

Primary Prevention

Gas gangrene can be prevented by always monitoring the blood glucose levels and maintaining them within the normal range, and regular foot inspection, most especially in those patients with diabetes. Post-exposure prophylaxis may be needed by immunocompromised individuals if they were in close contact with patients with necrotizing infection due to Group A streptococcus. Droplet and contact precautions are warranted to these susceptible individuals.

Secondary Prevention

Early diagnosis and prompt medical and surgical treatment of gangrene are needed to prevent the rapid progression and worsening of the disease.

Cost-Effectiveness of Therapy

Gangrene is a potential life-threatening condition if not given prompt treatment. Although the incidence is just low, gangrene can generate a high healthcare cost.

Future or Investigational Therapies

A novel gene therapeutic approach is currently conducted to promote reperfusion and angiogenesis of ischemic tissues, which can help in limb salvage. Ongoing study on this approach is conducted on mice and it involves the intramuscular injection of adeno-associated virus/ (AAV) vector, and E-selectin.

References

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Gangrene originated from a Greek word “sphacelus” that meant mortification of a human body part.[1][2] It was first used as a noun in the British Isles during the 16th century. Surgeons most often used it to refer to the cure of external human conditions. [2]

Historical Perspective

  • Gangrene originated from a Greek word “sphacelus” that meant mortification of a human body part. [1][2]
  • It was first used as a noun in the British Isles during the 16th century. [2]
  • Surgeons most often used it to refer to the cure of external human conditions. [2]
  • In the 17th century, this word was passed on from one person to another, until a metaphorical meaning was given by Shakespeare in Coriolanus:
                               "The service of the foote
                                Being once gangren'd, is not then respected
                                For what it was before." [2]
  • Pathology became a new profession in the 19th century, and has made gangrene as a taxonomical umbrella with a myriad of species flourished.
  • In 1915, gangrene was described by surgeon D’Arcy Power in his book Wounds of War:
 The wound generally becomes more or less emphysematous and discharges a thin brownish, offensive fluid, which contains bubbles of gas...
    The ineffective process continues after death and the swelling may rapidly become so great as to make the corpse unrecognizable.

Some Personalities With Significant Historical Contribution to the Discovery of Gangrene

  • Table 1 lists the famous people who had contracted gangrene.



Table 1.Personalities With Significant Historical Contribution to the Discovery of Gangrene.
Name Image Description
Jean Baptiste Lully
Jean Baptiste Lully.
(Image courtesy of Wikipedia)
  • French Baroque composer who had gangrene in January 1687.
  • While performing in his Te Deum, he stabbed his toe with a pointed material, which caused the spread of infection in his leg.
French King Louis XIV
French King Louis XIV.
(Image courtesy of Wikipedia)
Sebald Justinus Brugmans
Sebald Justinus Brugmans.
(Image courtesy of Wikipedia)
  • A professor at Leyden University, Brugsman became the lead expert against hospitalgangrene.
John M. Trombold
  • He was a surgeon during the American Civil War.
Father Camille Bulcke
Father Camille Bulcke.
(Image courtesy of Wikipedia)

References

  1. 1.0 1.1 Christopoulou-Aletra H, Papavramidou N (2009). “The manifestation of “gangrene” in the Hippocratic corpus”. Ann Vasc Surg. 23 (4): 548–51. doi:10.1016/j.avsg.2009.02.002. PMID 19540438.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Lawrence C (2005). “Gangrene”. Lancet. 366 (9498): 1689. doi:10.1016/S0140-6736(05)67683-0. PMID 16291052.
Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

There are three types of gangrene and they have different pathophysiology. A reduced arterial perfusion is observed in dry gangrene which results in the compensatory arteriolar dilation , which eventually results in distal edema, and damage of the endothelial tissue. [1] Saprogenic microorganisms such as Clostridium perfringens and Bacillus fusiformis are the most common organisms observed in wet gangrene which are responsible for infecting the tissues, thereby producing a putrid smell and edema. [2] Group A Steptococcus and exotoxins from Clostridium perfringens are responsible for the local and systemic infection found in gas gangrene.[3]

Pathophysiology

There are three types of gangrene and they have different pathophysiology.

Dry Gangrene

Wet Gangrene

Gas Gangrene

References

  1. 1.0 1.1 “StatPearls”. 2022. PMID 32809387 Check |pmid= value (help).
  2. 2.0 2.1 2.2 Al Wahbi A (2018). “Autoamputation of diabetic toe with dry gangrene: a myth or a fact?”. Diabetes Metab Syndr Obes. 11: 255–264. doi:10.2147/DMSO.S164199. PMC 5987754. PMID 29910628.
  3. 3.0 3.1 Lehner PJ, Powell H (1991). “Gas gangrene”. BMJ. 303 (6796): 240–2. doi:10.1136/bmj.303.6796.240. PMC 1670510. PMID 1884064.
  4. Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H; et al. (2015). “Interventions for treating gas gangrene”. Cochrane Database Syst Rev (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC 8652263 Check |pmc= value (help). PMID 26631369.
  5. Sakurai J, Nagahama M, Oda M (2004). “Clostridium perfringens alpha-toxin: characterization and mode of action”. J Biochem. 136 (5): 569–74. doi:10.1093/jb/mvh161. PMID 15632295.
Differentiating Gangrene from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Gangrene can have several mimicking conditions despite the unique presence of necrotic tissue.


Table 1. Differential Diagnosis of Gangrene. [1]
Differential Diagnosis Similar to:
Frostbite Ischemia
Ergotism Ischemia
Compartment syndrome Ischemia
Calciphylaxis Ischemia
Group A streptococcus infections Gas gangrene
Septic shock Gas gangrene
Toxic shock syndrome Gas gangrene

References

  1. “StatPearls”. 2022. PMID 32809387 Check |pmid= value (help).
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Ischemic or dry gangrene is commonly associated with peripheral artery disease (PAD). The most advanced stage of PAD is critical limb ischemia/ chronic limb-threatening ischemia, and it has an incidence rate of 1% in the United States. Gas gangrene is a rare condition, with an annual record of 1000 cases in the United States, 50% of which are due to traumatic injuries, 30% due to post-operative complications, and the remaining part is attributed to infections. [1]

References

  1. 1.0 1.1 1.2 1.3 1.4 Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H; et al. (2015). “Interventions for treating gas gangrene”. Cochrane Database Syst Rev (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC 8652263 Check |pmc= value (help). PMID 26631369.

Template:WH

Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

There are several risk factors for gangrene and these include penetrating trauma, blunt trauma, recent surgery, obesity, alcoholism, mucosal breach, skin breach, and immunosuppression. [1] [2] [3][4] [5] [6] [7] [8]

Risk Factors

There are several risk factors for gangrene and these include:

[3][4] [5] [6] [7] [8]

References

  1. 1.0 1.1 Stevens DL, Bryant AE (2017). “Necrotizing Soft-Tissue Infections”. N Engl J Med. 377 (23): 2253–2265. doi:10.1056/NEJMra1600673. PMID 29211672.
  2. 2.0 2.1 Anaya DA, Dellinger EP (2007). “Necrotizing soft-tissue infection: diagnosis and management”. Clin Infect Dis. 44 (5): 705–10. doi:10.1086/511638. PMID 17278065.
  3. 3.0 3.1 Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS; et al. (2005). “Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles”. N Engl J Med. 352 (14): 1445–53. doi:10.1056/NEJMoa042683. PMID 15814880.
  4. 4.0 4.1 Hasham S, Matteucci P, Stanley PR, Hart NB (2005). “Necrotising fasciitis”. BMJ. 330 (7495): 830–3. doi:10.1136/bmj.330.7495.830. PMC 556077. PMID 15817551.
  5. 5.0 5.1 Eneli I, Davies HD (2007). “Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program”. J Pediatr. 151 (1): 79–84, 84.e1. doi:10.1016/j.jpeds.2007.02.019. PMID 17586195.
  6. 6.0 6.1 Aebi C, Ahmed A, Ramilo O (1996). “Bacterial complications of primary varicella in children”. Clin Infect Dis. 23 (4): 698–705. doi:10.1093/clinids/23.4.698. PMID 8909829.
  7. 7.0 7.1 Beaudoin AL, Torso L, Richards K, Said M, Van Beneden C, Longenberger A; et al. (2014). “Invasive group A Streptococcus infections associated with liposuction surgery at outpatient facilities not subject to state or federal regulation”. JAMA Intern Med. 174 (7): 1136–42. doi:10.1001/jamainternmed.2014.1875. PMID 24861675.
  8. 8.0 8.1 Gupta Y, Chhetry M, Pathak KR, Jha RK, Ghimire N, Mishra BN; et al. (2016). “Risk Factors For Necrotizing Fasciitis And Its Outcome At A Tertiary Care Centre”. J Ayub Med Coll Abbottabad. 28 (4): 680–682. PMID 28586594.
Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Amputation and death are the most common consequence of critical limb ischemia/ chronic limb-threatening ischemia. [1] Gas gangrene has a higher fatality rate, ranging from 25% to 100%, if treatment is inadequate or delayed. Increased age, several comorbidities present, and involvement of trunk lead to a poor prognosis. [2]

Complications

Prognosis

References

  1. 1.0 1.1 Elsayed S, Clavijo LC (2015). “Critical limb ischemia”. Cardiol Clin. 33 (1): 37–47. doi:10.1016/j.ccl.2014.09.008. PMID 25439329.
  2. 2.0 2.1 Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H; et al. (2015). “Interventions for treating gas gangrene”. Cochrane Database Syst Rev (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC 8652263 Check |pmc= value (help). PMID 26631369.
  3. Landry GJ (2007). “Functional outcome of critical limb ischemia”. J Vasc Surg. 45 Suppl A: A141–8. doi:10.1016/j.jvs.2007.02.052. PMID 17544035.
  4. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R; et al. (2019). “Global vascular guidelines on the management of chronic limb-threatening ischemia”. J Vasc Surg. 69 (6S): 3S–125S.e40. doi:10.1016/j.jvs.2019.02.016. PMC 8365864 Check |pmc= value (help). PMID 31159978.
Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:Circulatory and respiratory system symptoms and signs

Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs



Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH